As Intelsius look to further expand their global network they are excited to announce a new distributor partnership with Jordan based, Naratech Pharma Consultancy. Established in 2007, Naratech have developed a reputation for providing Professional Pharma Quality support in the region and are actively engaged and dedicated to aiding companies engaged in drug development, storage, distribution as well as having deep connections with regional regulators. Focusing on best sustainable practice methods Naratech have grown considerably over the past decade servicing customers in the region and around the globe.

Intelsius were introduced to Naratech clients’ from across the Middle East at their annual cold chain event. The Arab Pharmaceutical Cold Supply Chain conference and exhibition was run for a sixth consecutive year from the 24th -25th of October. The conference based this year in Amman, Jordan brought together a variety of experts and regulators from within the Middle Eastern pharmaceutical sector to discuss major challenges and developments within the pharmaceutical supply chains in the Middle East.

The Pharmaceutical Cold Supply Chain Conference gave Intelsius a wonderful opportunity to showcase a variety of their passive temperature controlled solutions distributed by Naratech.

These systems include the Intelsius ORCA, a passive temperature controlled systems capable of maintaining temperature integrity for over 96 hours.
With Naratech acting as an Intelsius distributor serving Middle East customers, Intelsius has further extended their ability to satisfy their global customer base. Intelsius products can now be purchased from a multitude of sites with distributor coverage extending into all six major continents. To find your local branch please consult our contact us page.

By working with new global distributors Intelsius can further achieve the vision of “Protecting Life’s Most Precious Cargo” through the supply and design of innovative passive temperature controlled packaging solutions.

 

 

Twitter Icon Share on linkedin